KYLYS AESTHETICS Featured on Swiss National Television
KYLYS AESTHETICS was mentioned alongside TEOXANE Laboratories and AMiiA Clinique in a report broadcast by RTS – Radio Télévision Suisse, focusing on hyaluronic acid and its growing applications in aesthetic and regenerative medicine. For KYLYS AESTHETICS, this recognition reflects several years of dedicated work at the intersection of science and medical innovation. Since the […]
KYLYS Aesthetics Completes First Clinical Trial with 55 Patients Enrolled
Press Release KYLYS AESTHETICS SA successfully completes patient injections in its first clinical trial, enrolling 55 patients with promising preliminary outcomes. Geneva, Switzerland – February 6th, 2026 – KYLYS AESTHETICS SA, a Swiss clinical-stage biotech company developing next-generation regenerative aesthetic medical devices, today announces the successful completion of patient injections in its first […]
CHF 1 Million raised to accelerate our development
Press Release KYLYS AESTHETICS SA secures CHF 1 Million to accelerate development of next-generation hyaluronic acid-based medical devices. Geneva, Switzerland – June 18th, 2025 – KYLYS AESTHETICS SA, a Swiss biotech clinical stage company pioneering high-performance regenerative aesthetic solutions, proudly announces the successful closing of a CHF 1 million fundraising round by existing […]